dryadpublic
Data from: Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
ShareScore
28/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 8
- Access
- 12
- Reuse readiness
- 0
- Engagement
- 4